Press Releases
CORRECTING and REPLACING Quidel Reports Second Quarter 2008 Results
Business Wire | 2 hours 9 minutes ago
Conference call information, first U.S. dial-in number should read: 1-800-561-2601 (sted (888) 561-2601).... (more)
Cohen, Milstein, Hausfeld & Toll, P.L.L.C. Files Lawsuit Concerning Genentech Buyout
Business Wire | 3 hours 9 minutes ago
Cohen, Milstein, Hausfeld & Toll, P.L.L.C. has filed today a lawsuit in the Court of Chancery of the State of Delaware on behalf of Genentech Inc. (“Genentech” or the “Company”) (NYSE:DNA) shareholders concerning the proposed buy-out (the “Proposed Buy-Out”) of Genentech by its majority shareholder, Roche Holdings AG (“Roche”). The complaint alleges violations of breach of fiduciary duty, and aiding and abetting breaches of fiduciary duty with respect to Roche’s Proposed Buy-Out.... (more)
Neurocrine Biosciences Announces Conference Call and Webcast To Present Second Quarter 2008 Financial Results
PRNewswire | 3 hours 9 minutes ago
SAN DIEGO, July 23 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. ... (more)
Bausch & Lomb Names Alan Farnsworth as Senior Vice President of Customer Service & IT and CIO
Business Wire | 5 hours 8 minutes ago
Bausch & Lomb, the global eye health company, has named Alan H. Farnsworth as senior vice president of Customer Service & Information Technology and chief information officer. He remains a corporate vice president.... (more)
Mercy Health Plans Announces New Name for Their Medicare Advantage Plans: Mercy Medicare Advantage
PRNewswire | 5 hours 39 minutes ago
ST. LOUIS, July 23 /PRNewswire/ -- Mercy Health Plans, the St. Louis-based health benefits management company founded in 1994 by the Sisters of Mercy Health System, has announced it has changed the name of its Medicare Advantage plans to: Mercy MedicareAdvantage. The plans, which serve Medicare members in St. Louis, Illinois and Southwest Missouri, previously were offered using the names PremierPlus, PremierPlus Options, St. John's PremierPlus and St. John's PremierPlus Options.... (more)
Fitch: Roche's Ratings Placed On Rating Watch Negative
Business Wire | 8 hours 38 minutes ago
23 July 2008: Fitch Ratings has today placed Roche Holding Ltd.'s (Roche) 'AA' Long-term Issuer Default Rating (IDR) and 'F1+' Short-term IDR on Rating Watch Negative. The rating action arose from the company's offer to acquire the 44% of shares in Genentech not already owned for approximately USD43.7bn. The transaction is expected to be a cash merger whereby all outstanding Genentech shares and options, not held by Roche, will be converted into cash.... (more)
Bruker AXS SMART(TM) X2S Automated Chemical Crystallography System Wins Prestigious R&D 100 Award
Business Wire | 8 hours 39 minutes ago
Bruker AXS today announced that its SMART X2S automated chemical X-ray crystallography system has been awarded a R&D 100 award, recognizing it as one of the 100 most technologically significant products introduced in the past year. The R&D 100 Award winners are selected by an independent panel of judges and the editors of R&D Magazine. “The winning of an R&D 100 Award provides a mark of excellence known to industry, government, and academia as proof that the product is one of the most innovat...... (more)
Curis to Release Second Quarter 2008 Financial Results and Hold Conference Call on July 30, 2008
Business Wire | 8 hours 39 minutes ago
Curis, Inc. (NASDAQ:CRIS), a drug development company focused on developing proprietary targeted medicines primarily for cancer treatment, today announced that the Company will release its second quarter financial results on Wednesday, July 30, 2008 before the market opens. The Company will also hold a conference call on the same day at 9:00 A.M. Eastern time to discuss: (i) its Hedgehog antagonist program under collaboration with Genentech, (ii) CUDC-101 and other proprietary targeted cancer...... (more)
Vaccine Executive Staph Bakali Joins Genocea Biosciences' Board of Directors
Business Wire | 8 hours 39 minutes ago
Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has added Mustapha Leavenworth Bakali to its Board of Directors as Executive Director.... (more)
US Investigations Services, Inc. (USIS) invitation for Investor Update conference call
Business Wire | 9 hours 8 minutes ago
US Investigations Services, Inc. (USIS) will conduct an investor conference call at 3:00 p.m. Eastern, Wednesday, July 23, 2008. USIS Chief Executive Officer Randy Dobbs, incoming CEO Michael Cherkasky (formerly President and CEO of Marsh & McLennan Companies), and Chief Financial Officer David Kaminsky will provide an investor update.... (more)
USIS CEO Randy Dobbs to become Executive Chairman of USIS Boards of Directors; Michael G. Cherkasky to assume duties as USIS CEO
Business Wire | 9 hours 8 minutes ago
Randy Dobbs, Chief Executive Officer of US Investigations Services, Inc. and its subsidiaries (USIS), will transition to a new role at the company, becoming the Executive Chairman of the USIS Boards of Directors. Michael G. Cherkasky, formerly the President and CEO of Marsh & McLennan Companies, Inc. (MMC), the global professional services firm, will become the CEO of USIS and serve on the corporation’s boards of directors. The changes are effective Aug. 1, 2008.... (more)
Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
PRNewswire | 10 hours 39 minutes ago
SEATTLE, July 23 /PRNewswire-FirstCall/ -- Dendreon Corporation ... (more)
Dyax Corp. Announces Second Quarter 2008 Financial Results
Business Wire | 10 hours 39 minutes ago
Dyax Corp. (NASDAQ: DYAX) today announced financial results for the second quarter ended June 30, 2008. Dyax will host a webcast and conference call at 10 a.m. (ET) this morning to review the financial results and corporate progress for the quarter.... (more)
Pfizer Reports Second-Quarter 2008 Results
Business Wire | 11 hours 9 minutes ago
Pfizer Inc (NYSE: PFE):... (more)
49 Press Releases | 
RSS Feed
Sign up for AABB SmartBrief
Companies in the news
- BioSante Pharmaceuticals, Inc.
- Biogen IDEC Inc.
- Cape Cod Hospital
- Exelixis Inc
- Galapagos NV
- Genentech Inc
- Imclone Systems Inc
- Isotechnika
- Logistics
- Lorus Therapeutics Inc.
- MediGene AG
- Omrix Biopharmaceuticals Ltd.
- Palms West Hospital
- Robert Wood Johnson University Hospital
- Vical Incorporated